SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Infinity Pharmaceuticals Inc. Reports IPI-145 Phase 1 Data Showing Clinical Activity in B-Cell and T-Cell Malignancies at American Society of Hematology Annual Meeting